Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mireya Fuentes

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2012
Proteasome inhibition reduces proliferation, collagen expression, and inflammatory cytokine production in nasal mucosa and polyp fibroblastsLaura Pujols, Laura Fernández-Bertolín, Mireya Fuentes-Prado, et al.
Plos One|June 20, 2014
Reconstituted human upper airway epithelium as 3-d in vitro model for nasal polyposisFrancisco de Borja Callejas, Asunción Martínez-Antón, Isam Alobid, et al.
Immunologic Research|December 1, 2022
Effect of MP-AzeFlu in IL-1 beta-induced IL-6 and proinflammatory cytokinesSònia Vicens-Artés, Jordi Roca-Ferrer, Valeria Tubita, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 23, 2022
Superior effect of MP-AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP-1 and TTP anti-inflammatory gene expression in healthy and inflamed upper airway mucosaSònia Vicens-Artés, Jordi Roca-Ferrer, Valeria Tubita, et al.
Immunity, Inflammation and Disease|January 27, 2023
Effect of MP-AzeFlu compared to monotherapy on COX-2, PGE<sub>2</sub> , and EP2 gene expression in upper airway mucosaSonia Vicens-Artes, Jordi Roca-Ferrer, Valeria Tubita, et al.
Allergy|April 7, 2020
Integrated mRNA and microRNA transcriptome profiling during differentiation of human nasal polyp epithelium reveals an altered ciliogenesisBorja Callejas-Díaz, Guerau Fernandez, Mireya Fuentes, et al.
International Archives of Allergy and Immunology|March 8, 2014
Fluticasone furoate inhibits cytokine secretion from nasal epithelial cells and reduces eosinophil survival in an in vitro model of eosinophilic inflammationJoaquim Mullol, Laura Pujols, Isam Alobid, et al.
Journal of Clinical Medicine|December 9, 2023
Upregulation of Platelet-Activating Factor Receptor Expression and Lyso-Platelet-Activating Factor Isoforms in Human Nasal Polyp TissuesJordi Roca-Ferrer, Maria Pérez-González, Isam Alobid, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 22, 2018
Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markersJordi Roca-Ferrer, Laura Pujols, Maria Pérez-González, et al.
The European Respiratory Journal|March 28, 2025
Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trialGuadalupe Bermudo-Peloche, Belén Del Rio, Vanesa Vicens-Zygmunt, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2012
Proteasome inhibition reduces proliferation, collagen expression, and inflammatory cytokine production in nasal mucosa and polyp fibroblastsLaura Pujols, Laura Fernández-Bertolín, Mireya Fuentes-Prado, et al.
Plos One|June 20, 2014
Reconstituted human upper airway epithelium as 3-d in vitro model for nasal polyposisFrancisco de Borja Callejas, Asunción Martínez-Antón, Isam Alobid, et al.
Immunologic Research|December 1, 2022
Effect of MP-AzeFlu in IL-1 beta-induced IL-6 and proinflammatory cytokinesSònia Vicens-Artés, Jordi Roca-Ferrer, Valeria Tubita, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 23, 2022
Superior effect of MP-AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP-1 and TTP anti-inflammatory gene expression in healthy and inflamed upper airway mucosaSònia Vicens-Artés, Jordi Roca-Ferrer, Valeria Tubita, et al.
Immunity, Inflammation and Disease|January 27, 2023
Effect of MP-AzeFlu compared to monotherapy on COX-2, PGE<sub>2</sub> , and EP2 gene expression in upper airway mucosaSonia Vicens-Artes, Jordi Roca-Ferrer, Valeria Tubita, et al.
Allergy|April 7, 2020
Integrated mRNA and microRNA transcriptome profiling during differentiation of human nasal polyp epithelium reveals an altered ciliogenesisBorja Callejas-Díaz, Guerau Fernandez, Mireya Fuentes, et al.
International Archives of Allergy and Immunology|March 8, 2014
Fluticasone furoate inhibits cytokine secretion from nasal epithelial cells and reduces eosinophil survival in an in vitro model of eosinophilic inflammationJoaquim Mullol, Laura Pujols, Isam Alobid, et al.
Journal of Clinical Medicine|December 9, 2023
Upregulation of Platelet-Activating Factor Receptor Expression and Lyso-Platelet-Activating Factor Isoforms in Human Nasal Polyp TissuesJordi Roca-Ferrer, Maria Pérez-González, Isam Alobid, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 22, 2018
Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markersJordi Roca-Ferrer, Laura Pujols, Maria Pérez-González, et al.
The European Respiratory Journal|March 28, 2025
Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trialGuadalupe Bermudo-Peloche, Belén Del Rio, Vanesa Vicens-Zygmunt, et al.
Pageof 2